Newsroom

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...

PARIS--(BUSINESS WIRE)--In an energy context marked by rising petroleum and gas products prices, TotalEnergies (Paris:TTE) (LSE:TTE) (NYSE:TTE) has made it a clear priority to share the Company’s success and performance with its employees by strengthening value-sharing mechanisms and specific measures to support their energy purchasing power. An Exceptional Value-Sharing Bonus in 2026 TotalEnergies has confirmed that it will distribute an exceptional value-sharing bonus to eligible employees1 i...

HENDERSON, Nev.--(BUSINESS WIRE)--Zura Bio Limited (Nasdaq: ZURA) (“Zura”), a clinical-stage biotechnology company developing novel and differentiated medicines to meaningfully improve the lives of patients with serious and debilitating autoimmune and inflammatory diseases, today announced financial results for the third quarter ended September 30, 2026, and provided recent corporate updates. “Our team continues to execute efficiently on our development plan for tibulizumab, and we are excited...

FAIRPORT, N.Y.--(BUSINESS WIRE)--Monro, Inc. (Nasdaq: MNRO), a leading provider of automotive repair and tire services, today announced that Peter Fitzsimmons, President and Chief Executive Officer, Brian D’Ambrosia, Executive Vice President and Chief Financial Officer, and Felix Veksler, Vice President of Investor Relations, will participate in a Fireside Chat at the Gabelli 50th Annual Automotive Symposium on Tuesday, November 3, 2026 at 2:00 PM PT. A live webcast of the Gabelli event will be...

NEW YORK--(BUSINESS WIRE)--Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, will present data related to its NGN-401 gene therapy program for Rett syndrome at the European Society of Gene and Cell Therapy (ESGCT) 33rd Annual Congress, taking place October 27-30, 2026, in Hamburg, Germany. The new preclinical data are expected to further validate NGN-401’s differentiated desig...

CLEVELAND--(BUSINESS WIRE)--Lincoln Electric (NASDAQ:LECO) reports a 15% increase in Net sales to $1.221 billion and a 21% increase in Adjusted EPS of $2.98 for Q3-2026....

COLUMBUS, Ohio--(BUSINESS WIRE)--OH.io, the first-of-its-kind go-to-market performance venture firm, and CVAT, the open-source platform for labeling image, video, 3D point cloud, and audio data at scale to train artificial intelligence, today announced a partnership that brings CVAT into the OH.io portfolio. CVAT will receive dedicated sales and marketing support, along with a $2 million investment from OH.io Capital, OH.io's sister company. CVAT started as an internal tool at Intel in 2017 and...

LONDON & AMSTERDAM & NEW YORK--(BUSINESS WIRE)--Intercontinental Exchange, Inc. (NYSE: ICE), one of the world’s leading providers of financial market technology and data powering global capital markets, and home to the largest and most liquid markets to trade energy derivatives, today announced that on October 23, 2026, open interest (OI) across ICE TTF options reached a record of over 3 million contracts, up 33% year-over-year (y/y). On the same day, ICE TTF futures and options hit record OI o...

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) will hold an Enterprise Business Review for the investment community on Tuesday, December 8th, 2026. During the event, Company leaders will provide a detailed review of the Innovative Medicine and MedTech businesses, highlight how their pipelines are shaping the future of healthcare, and discuss the Company’s long-term strategy for delivering the next wave of growth and shareholder value. The Enterprise Business Review will...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...